Kumari P, Sullivan L, Li Z, Parker Conquest E, Cornforth E, Jayakumar R
Nat Commun. 2025; 16(1):2158.
PMID: 40044661
PMC: 11882899.
DOI: 10.1038/s41467-025-56479-5.
Al-Abri R, Gursoy G
bioRxiv. 2025; .
PMID: 40027646
PMC: 11870476.
DOI: 10.1101/2025.02.15.638440.
Carrascosa-Saez M, Colom-Rodrigo A, Gonzalez-Martinez I, Perez-Gomez R, Garcia-Rey A, Piqueras-Losilla D
Lab Anim (NY). 2025; .
PMID: 40016516
DOI: 10.1038/s41684-025-01506-7.
Qie B, Tuo J, Chen F, Ding H, Lyu L
MedComm (2020). 2025; 6(2):e70091.
PMID: 39949979
PMC: 11822459.
DOI: 10.1002/mco2.70091.
Srinivasan A, Magner D, Kozlowski P, Philips A, Kajdasz A, Wojciechowski P
Hum Genet. 2025; .
PMID: 39903274
DOI: 10.1007/s00439-025-02729-x.
Identifying Genetic Predisposition to Dozer Lamb Syndrome: A Semi-Lethal Muscle Weakness Disease in Sheep.
Stegemiller M, Highland M, Ewert K, Neaton H, Biller D, Murdoch B
Genes (Basel). 2025; 16(1).
PMID: 39858630
PMC: 11764822.
DOI: 10.3390/genes16010083.
The Plethora of RNA-Protein Interactions Model a Basis for RNA Therapies.
Dansereau S, Cui H, Dartawan R, Sheng J
Genes (Basel). 2025; 16(1).
PMID: 39858595
PMC: 11765398.
DOI: 10.3390/genes16010048.
The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1.
Provenzano M, Ikegami K, Bates K, Gaynor A, Hartman J, Jones A
J Clin Invest. 2025; 135(4).
PMID: 39836447
PMC: 11827844.
DOI: 10.1172/JCI185426.
RNA gain-of-function mechanisms in short tandem repeat diseases.
Davenport M, Swanson M
RNA. 2024; 31(3):349-358.
PMID: 39725460
PMC: 11874975.
DOI: 10.1261/rna.080277.124.
Resolving the chromatin impact of mosaic variants with targeted Fiber-seq.
Bohaczuk S, Amador Z, Li C, Mallory B, Swanson E, Ranchalis J
Genome Res. 2024; 34(12):2269-2278.
PMID: 39653420
PMC: 11694741.
DOI: 10.1101/gr.279747.124.
A phenome-wide association study of tandem repeat variation in 168,554 individuals from the UK Biobank.
Manigbas C, Jadhav B, Garg P, Shadrina M, Lee W, Altman G
Nat Commun. 2024; 15(1):10521.
PMID: 39627187
PMC: 11614882.
DOI: 10.1038/s41467-024-54678-0.
Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Annane D, Laberge L, Gallais B, Chevret S
Cochrane Database Syst Rev. 2024; 11:CD003218.
PMID: 39555632
PMC: 11571272.
DOI: 10.1002/14651858.CD003218.pub3.
Dominantly inherited muscle disorders: understanding their complexity and exploring therapeutic approaches.
Findlay A
Dis Model Mech. 2024; 17(10).
PMID: 39501809
PMC: 11574355.
DOI: 10.1242/dmm.050720.
Structural and Dynamical Properties of Nucleic Acid Hairpins Implicated in Trinucleotide Repeat Expansion Diseases.
Pan F, Xu P, Roland C, Sagui C, Weninger K
Biomolecules. 2024; 14(10).
PMID: 39456210
PMC: 11505666.
DOI: 10.3390/biom14101278.
RNA mis-splicing in children with congenital myotonic dystrophy is associated with physical function.
Hartman J, Ikegami K, Provenzano M, Bates K, Butler A, Jones A
Ann Clin Transl Neurol. 2024; 11(12):3175-3191.
PMID: 39450929
PMC: 11651218.
DOI: 10.1002/acn3.52224.
Altered drug metabolism and increased susceptibility to fatty liver disease in a mouse model of myotonic dystrophy.
Dewald Z, Adesanya O, Bae H, Gupta A, Derham J, Chembazhi U
Nat Commun. 2024; 15(1):9062.
PMID: 39433769
PMC: 11494077.
DOI: 10.1038/s41467-024-53378-z.
MBL-1/Muscleblind regulates neuronal differentiation and controls the splicing of a terminal selector in Caenorhabditis elegans.
Lee H, Lim H, He H, Lau C, Zheng C
PLoS Genet. 2024; 20(10):e1011276.
PMID: 39423233
PMC: 11524483.
DOI: 10.1371/journal.pgen.1011276.
Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1.
Hicks S, Frias J, Mishra S, Scotti M, Muscato D, Valero M
Mol Ther Nucleic Acids. 2024; 35(4):102338.
PMID: 39391766
PMC: 11465180.
DOI: 10.1016/j.omtn.2024.102338.
AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action.
Cerro-Herreros E, Nunez-Manchon J, Naldaiz-Gastesi N, Carrascosa-Saez M, Garcia-Rey A, Losilla D
Sci Adv. 2024; 10(41):eadn6525.
PMID: 39383229
PMC: 11463307.
DOI: 10.1126/sciadv.adn6525.
Molecular Pathology of Myotonic Dystrophy Type 1 in Iceland.
Hallgrimsdottir E, Svansson H, Stefansdottir V, Sveinsson O, Olafsdottir H, Briem E
Mol Genet Genomic Med. 2024; 12(10):e70013.
PMID: 39373365
PMC: 11457208.
DOI: 10.1002/mgg3.70013.